Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Clinical trial NCT02982941 · COMPLETED

Trial details

NCT number: NCT02982941
Sponsor: MacroGenics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroblastoma Rhabdomyosarcoma Osteosarcoma Ewing Sarcoma Wilms Tumor Desmoplastic Small Round Cell Tumor

Start date: 2016-12-01
Primary completion: 2019-05-22
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.